161 related articles for article (PubMed ID: 16914587)
1. Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1.
Juarez JC; Betancourt O; Pirie-Shepherd SR; Guan X; Price ML; Shaw DE; Mazar AP; Doñate F
Clin Cancer Res; 2006 Aug; 12(16):4974-82. PubMed ID: 16914587
[TBL] [Abstract][Full Text] [Related]
2. Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224).
Doñate F; Juarez JC; Burnett ME; Manuia MM; Guan X; Shaw DE; Smith EL; Timucin C; Braunstein MJ; Batuman OA; Mazar AP
Br J Cancer; 2008 Feb; 98(4):776-83. PubMed ID: 18253124
[TBL] [Abstract][Full Text] [Related]
3. Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling.
Juarez JC; Manuia M; Burnett ME; Betancourt O; Boivin B; Shaw DE; Tonks NK; Mazar AP; Doñate F
Proc Natl Acad Sci U S A; 2008 May; 105(20):7147-52. PubMed ID: 18480265
[TBL] [Abstract][Full Text] [Related]
4. Copper chelator ATN-224 inhibits endothelial function by multiple mechanisms.
Lowndes SA; Sheldon HV; Cai S; Taylor JM; Harris AL
Microvasc Res; 2009 May; 77(3):314-26. PubMed ID: 19323979
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
6. Superoxide generated by lysophosphatidylcholine induces endothelial nitric oxide synthase downregulation in human endothelial cells.
Choi S; Park S; Liang GH; Kim JA; Suh SH
Cell Physiol Biochem; 2010; 25(2-3):233-40. PubMed ID: 20110684
[TBL] [Abstract][Full Text] [Related]
7. Targeting SOD1 reduces experimental non–small-cell lung cancer.
Glasauer A; Sena LA; Diebold LP; Mazar AP; Chandel NS
J Clin Invest; 2014 Jan; 124(1):117-28. PubMed ID: 24292713
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of superoxide dismutase 1 by PMA is involved in cell fate determination and mediated via protein kinase D2 in myeloid leukemia cells.
Chen YL; Kan WM
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2662-75. PubMed ID: 26241492
[TBL] [Abstract][Full Text] [Related]
9. Redox-related antimelanoma activity of ATN-224.
Trapp V; Lee K; Doñate F; Mazar AP; Fruehauf JP
Melanoma Res; 2009 Dec; 19(6):350-60. PubMed ID: 22760066
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors.
Lowndes SA; Adams A; Timms A; Fisher N; Smythe J; Watt SM; Joel S; Donate F; Hayward C; Reich S; Middleton M; Mazar A; Harris AL
Clin Cancer Res; 2008 Nov; 14(22):7526-34. PubMed ID: 19010871
[TBL] [Abstract][Full Text] [Related]
12. The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies.
Lee K; Briehl MM; Mazar AP; Batinic-Haberle I; Reboucas JS; Glinsmann-Gibson B; Rimsza LM; Tome ME
Free Radic Biol Med; 2013 Jul; 60():157-67. PubMed ID: 23416365
[TBL] [Abstract][Full Text] [Related]
13. The Cu-Zn superoxide dismutase (SOD1) inhibits ERK phosphorylation by muscarinic receptor modulation in rat pituitary GH3 cells.
Secondo A; De Mizio M; Zirpoli L; Santillo M; Mondola P
Biochem Biophys Res Commun; 2008 Nov; 376(1):143-7. PubMed ID: 18765227
[TBL] [Abstract][Full Text] [Related]
14. Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.
Calderon-Aparicio A; Strasberg-Rieber M; Rieber M
Oncotarget; 2015 Oct; 6(30):29771-81. PubMed ID: 26356671
[TBL] [Abstract][Full Text] [Related]
15. Propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells.
Lamy S; Lachambre MP; Lord-Dufour S; Béliveau R
Vascul Pharmacol; 2010; 53(5-6):200-8. PubMed ID: 20732454
[TBL] [Abstract][Full Text] [Related]
16. The effect of tetrathiomolybdate on cytokine expression, angiogenesis, and tumor growth in squamous cell carcinoma of the head and neck.
Teknos TN; Islam M; Arenberg DA; Pan Q; Carskadon SL; Abarbanell AM; Marcus B; Paul S; Vandenberg CD; Carron M; Nor JE; Merajver SD
Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):204-11. PubMed ID: 15781759
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth.
Doñate F; Parry GC; Shaked Y; Hensley H; Guan X; Beck I; Tel-Tsur Z; Plunkett ML; Manuia M; Shaw DE; Kerbel RS; Mazar AP
Clin Cancer Res; 2008 Apr; 14(7):2137-44. PubMed ID: 18381955
[TBL] [Abstract][Full Text] [Related]
18. EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation.
Sun HL; Tsai AC; Pan SL; Ding Q; Yamaguchi H; Lin CN; Hung MC; Teng CM
Clin Cancer Res; 2009 Aug; 15(15):4904-14. PubMed ID: 19622586
[TBL] [Abstract][Full Text] [Related]
19. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
20. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
